Resources2021-12-06T11:12:21-05:00

Established Use With Industry-Leading Partners

Epiontis ID has been used in phase 1 to phase 3 studies by some of the most prominent biopharmaceutical companies around the world. Explore the work our Epiontis team has conducted with these industry leaders.

Selection of Recent Publications